EX 527 (CAS: 49843-98-3)
|
SKU-Pack Size | Availability | Size | Price | |
EBC51040-1ML | In Stock | 1mL(10mM in DMSO) |
|
|
EBC51040-5MG | In Stock | 5mg |
|
|
EBC51040-10MG | In Stock | 10mg |
|
|
EBC51040-25MG | In Stock | 25mg |
|
|
EBC51040-50MG | In Stock | 50mg |
|
Please Select The Country You Are In To Find Your Local Distributor. |
SBT BioChem Srl | Phone£º+39 05 7156 8147 | |
Via Ponte di Bagnolo, 811 Bologna, | E-mail£ºinfo@sbtbiochem.it | |
Italy | Italy | Web£ºwww.sbtbiochem.it |
Product Information | |||||||||||||||||||||
Synonym(s) | EX-527, SEN0014196, Selisistat | ||||||||||||||||||||
Chemical Name | 6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide | ||||||||||||||||||||
Application | EX 527 is a potent inhibitor of the SIRT1 class III histone deacetylase enzyme, selective over SIRT2 and SIRT3. | ||||||||||||||||||||
CAS Number | 49843-98-3 | ||||||||||||||||||||
Purity | ¡Ý98.0% | ||||||||||||||||||||
Molecular Weight | 248.71 | ||||||||||||||||||||
Molecular Formula | C₁₃H₁₃ClN₂O | ||||||||||||||||||||
SMILES | O=C(C1C(NC2=C3C=C(Cl)C=C2)=C3CCC1)N | ||||||||||||||||||||
Target & IC50 | SIRT1: IC50 = 98 nM SIRT2: IC50 = 19.6 ¦ÌM SIRT3: IC50 = 48.7 ¦ÌM |
||||||||||||||||||||
Solubility | DMSO: 49 mg/mL (197.02 mM) Ethanol: 30 mg/mL (120.62 mM) |
||||||||||||||||||||
Preparing Stock Solutions |
|
||||||||||||||||||||
Shipping | Gel Pack | ||||||||||||||||||||
Storage | Store at 4¡ã C | ||||||||||||||||||||
Research Use | For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |
Product Description | |
Selisistat (EX-527) is an inhibitor of SIRT1 enzymatic activity (IC50, 98 nM), identified in a high-throughput screen using bacterially expressed human SIRT1. Selisistat (EX-527) inhibits SIRT1 in a concentration-dependent manner with an IC50 of 38 nM, in agreement with the activity on bacterially expressed SIRT1. Selisistat (EX-527) has much lower potency against SIRT2 (IC50, 19.6 μM) or SIRT3 (IC50, 48.7 μM) but does not inhibit class I/II HDAC activity at concentrations up to 100 μM. Selisistat (EX-527) exerts an inhibitory effect on SIRT1 activity without affecting SIRT1 expression on both mRNA and protein levels. |
Specific Protocols | |